DefaultUser

Jeffrey R. Strawn, MD

Attending Physician, Division of Child and Adolescent Psychiatry

Assistant Professor, UC Department of Psychiatry and Behavioral Neuroscience

Phone 513-636-4788

Email strawnjr@uc.edu

Pediatric anxiety disorders; psychopharmacology; psychotherapy

Dr. Strawn’s current research involves the identification of risk factors for pediatric anxiety disorders as well as the pathophysiology and psychopharmacology of these conditions. He uses functional neuroimaging and magnetic resonance spectroscopy to study the neurophysiology of pediatric generalized anxiety disorder and of the neurophysiologic effects of co-morbid anxiety on the neurobiology of other psychiatric conditions in children and adolescents. Additionally, Dr. Strawn utilizes functional magnetic resonance imaging to identify medication-related changes in brain circuits that precede clinical improvement. This work may identify early predictors of treatment response and may guide treatment choice in pediatric patients with anxiety disorders. Finally, he actively conducts clinical trials in youth with mood and anxiety disorders.

Dr. Strawn has authored more than 75 peer-reviewed publications and is a member of the American Academy of Child & Adolescent Psychiatry, the Anxiety Disorders Association of America and has been elected to Alpha Omega Alpha. Additionally, he is the recipient of numerous awards for teaching and research.

MD: University of Cincinnati, Cincinnati, OH, 2005.

Residency: University of Cincinnati, Cincinnati, OH. 

Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH. 

Certification: Diplomate, American Board of Psychiatry and Neurology – General Psychiatry; American Board of Psychiatry and Neurology – Child & Adolescent Psychiatry.

Strawn JR, John Wegman C, Dominick KC, Swartz MS, Wehry AM, Patino LR, Strakowski SM, Adler CM, Eliassen JC, DelBello MP. Cortical surface anatomy in pediatric patients with generalized anxiety disorder. Journal of Anxiety Disorders. 2014;28(7):717-23.

Strawn JR, Wehry AM, Chu WJ, Adler CM, Eliassen JC, Cerullo MA, Strakowski SM, Delbello MP. Neuroanatomic abnormalities in adolescents with generalized anxiety disorder: a voxel-based morphometry study. Depression & Anxiety. 2013;30(9):842-8.

Strawn JR, Sakolsky DJ, Rynn MA. Psychopharmacologic treatment of anxiety disorders in children and adolescents. Child & Adolescent Psychiatric Clinics of North America. 2012;21(3):527-539.

McNamara RK, Strawn JR, Chang KD, DelBello MP. Interventions for Youth at High Risk for Bipolar Disorder and SchizophreniaChild Adolescent Psychiatric Clinics of North America. 2012;21:739–51.

Strawn JR, Bitter SM, Adler CM, Chu W, Eliassen JC, Whitsel R, Weber WA, Cerullo MA, Strakowski SM, DelBello MP. Neurocircuitry of generalized anxiety disorder in adolescents: a pilot functional magnetic resonance and functional connectivity study. Depression & Anxiety. 2012;29(11):939-47.

Strawn JR, Patel NC, Chu W-J, Lee JH, Adler CM, Kim MJ, Bryan H, Alfieri DC, Welge JA, Blom TJ, Nandagopal J, Strakowski SM, DelBello MP. Glutamatergic effects of divalproex in adolescents with mania: A proton magnetic resonance spectroscopy study. Journal of the American Academy of Child & Adolescent Psychiatry. 2012;51(6):642-651.

Strawn JR, Wehry AM, DelBello MP, Rynn MA, Strakowski SM. Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder. Depression & Anxiety. 2012;29:328-339.

Delgado SV, Strawn JR. Termination in psychodynamic psychotherapy with adolescents: a review and contemporary perspective. Bulletin of the Menninger Clinic. 2012;76(1):21-52.

Strawn JR, Keeshin BR, Geracioti TD, DelBello MP, Putnam FW. Psychopharmacologic treatment of posttraumatic stress disorder in children and adolescents. Journal of Clinical Psychiatry. 2010;71(7):932-941.

Sah R, Ekhator NN, Strawn JR, Sallee FR, Horn PS, Geracioti TD, Jr. Low cerebrospinal fluid neuropeptide Y concentrations in patients with posttraumatic stress disorder. Biological Psychiatry. 2009;66(7):705-707.

Neurofunctional Predictors of Treatment Response in Adolescents with GAD. National Institutes of Health/National Institute of Mental Health. Sep 2014–Aug 2018. MH106037.